Adherence to antidepressant treatment

References

• Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51(1), 8–19 (1994)
   Google Scholar
• Judd LL. The clinical course of unipolar major depressivve disorders. Arch. Gen. Psychiatry 54(11), 989–991 (1997).
   Google Scholar
• Keller MB, Lavori PW, Mueller TI et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch. Gen. Psychiatry 49(10), 809–816 (1992).
   PubMed Web of Science ®Google Scholar
• Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol. Psychiatry 44(5), 348–360 (1998).
   PubMed Web of Science ®Google Scholar
• Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am. J. Psychiatry 157(12), 1925–1932 (2000).
   PubMed Web of Science ®Google Scholar
• Mueller TI, Leon AC, Keller MB et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am. J. Psychiatry 156(7), 1000–1006 (1999).
   PubMed Web of Science ®Google Scholar
• Kessing LV, Hansen MG, Andersen PK, Angst J. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders – a life-long perspective. Acta Psychiatr. Scand. 109(5), 339–344 (2004).
   PubMed Web of Science ®Google Scholar
• Solomon DA, Keller MB, Leon AC et al. Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Arch. Gen. Psychiatry 54(11), 1001–1006 (1997).
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS, Zeller PJ et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch. Gen. Psychiatry 57(4), 375–380 (2000).
   PubMed Web of Science ®Google Scholar
• Coryell W, Scheftner W, Keller M et al. The enduring psychosocial consequences of mania and depression. Am. J. Psychiatry 150(5), 720–727 (1993).
   PubMed Web of Science ®Google Scholar
• Hays RD, Wells KB, Sherbourne CD et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch. Gen. Psychiatry 52(1), 11–19 (1995).
   PubMed Web of Science ®Google Scholar
• Kessing LV. Cognitive impairment in the euthymic phase of affective disorder. Psychol. Med. 28(5), 1027–1038 (1998).
   PubMed Web of Science ®Google Scholar
• Geddes JR, Carney SM, Davies C et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361(9358), 653–661 (2003).
   PubMed Web of Science ®Google Scholar
• Melfi CA, Chawla AJ, Croghan TW et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch. Gen. Psychiatry 55(12), 1128–1132 (1998).
   PubMed Web of Science ®Google Scholar
• Claxton AJ, Li Z, McKendrick J. Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression. Br. J. Psychiatry 177, 163–168 (2000).
   PubMed Web of Science ®Google Scholar
• Moller HJ, Demyttenaere K, Sacchetti E et al. Improving the chance of recovery from the short- and long-term consequences of depression. Int. Clin. Psychopharmacol. 18(4), 219–225 (2003).
   PubMed Web of Science ®Google Scholar
• Guscott R, Taylor L. Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness and efficiency. Br. J. Psychiatry 164(6), 741–746 (1994).
   PubMed Web of Science ®Google Scholar
• Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr. Scand. 105(3), 164–172 (2002).
   PubMed Web of Science ®Google Scholar
• Heath I. A wolf in sheep’s clothing: a critical look at the ethics of drug taking. Br. Med. J. 327(7419), 856–858 (2003).
   PubMedGoogle Scholar
• Frank E, Judge R. Treatment recommendations versus treatment realities: recognizing the rift and understanding the consequences. J. Clin. Psychiatry 62(Suppl. 22), 10–15 (2001).
   PubMedGoogle Scholar
• Demyttenaere K. Risk factors and predictors of compliance in depression. Eur. Neuropsychopharmacol. 13(Suppl. 3), S69–S75 (2003).
   PubMed Web of Science ®Google Scholar
• Lepine JP, Gastpar M, Mendlewicz J, Tylee A. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int. Clin. Psychopharmacol. 12(1), 19–29 (1997).
   PubMed Web of Science ®Google Scholar
• Bauer M, Whybrow PC, Angst J et al. Federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J. Biol. Psychiatry 3(2), 69–86 (2002).
   PubMedGoogle Scholar
• American PsychiatricAssociation. Practice guideline for the treatment of patients with major depressive disorder (revision). Am. J. Psychiatry 157(Suppl. 4), 1–45 (2000).
   Google Scholar
• Demyttenaere K. Noncompliance with antidepressants: who's to blame? Int. Clin. Psychopharmacol. 13(Suppl. 2), S19–S25 (1998).
   Google Scholar
• Munizza C, Tibaldi G, Bollini P et al. Prescription pattern of antidepressants in out-patient psychiatric practice. Psychol. Med. 25(4), 771–778 (1995).
   Google Scholar
• Hansen DG, Vach W, Rosholm JU et al. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam. Pract. 21(6), 623–629 (2004).
   PubMedGoogle Scholar
• Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr. Serv. 49(2), 196–201 (1998).
   PubMed Web of Science ®Google Scholar
• Keller MB, Hirschfeld RM, Demyttenaere K, Baldwin DS. Optimizing outcomes in depression: focus on antidepressant compliance. Int. Clin. Psychopharmacol. 17(6), 265–271 (2002).
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Haddad P. Compliance with antidepressant therapy and antidepressant discontinuation symptoms. Acta Psychiatr. Scand. 403(Suppl.), 50–56 (2000).
   Web of Science ®Google Scholar
• Bull SA, Hu XH, Hunkeler EM et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 288(11), 1403–1409 (2002).
   PubMed Web of Science ®Google Scholar
• Bull SA, Hunkeler EM, Lee JY et al. Discontinuing or switching selective serotonin-reuptake inhibitors. Ann. Pharmacother. 36(4), 578–584 (2002).
   PubMed Web of Science ®Google Scholar
• Brown C, Battista DR, Bruehlman R et al. Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med. Care. 43(12), 1203–1207 (2005).
   PubMed Web of Science ®Google Scholar
• Priest RG, Vize C, Roberts A et al. Lay people’s attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. Br. Med. J. 313(7061), 858–859 (1996).
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Enzlin P, Dewe W et al. Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. J. Clin. Psychiatry 62(Suppl. 22), 30–33 (2001).
   PubMed Web of Science ®Google Scholar
• Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 130(Suppl. 1), S65– S72 (2006).
   PubMed Web of Science ®Google Scholar
• Kessing LV, Hansen HV, Demyttenaere K, Bech P. Depressive and bipolar disorders: patients' attitudes and beliefs towards depression and antidepressants. Psychol. Med. 35(8), 1205–1213 (2005).
   PubMed Web of Science ®Google Scholar
• Bollini P, Tibaldi G, Testa C, Munizza C. Understanding treatment adherence in affective disorders: a qualitative study. J. Psychiatr. Ment. Health Nurs. 11(6), 668–674 (2004).
   PubMedGoogle Scholar
• Aikens JE, Nease DE Jr, Nau DP et al. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann. Fam. Med. 3(1), 23–30 (2005).
   PubMed Web of Science ®Google Scholar
• Barbui C, Hotopf M, Freemantle N et al. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Cochrane. Database. Syst. Rev. 4, CD002791 (2000).
   Google Scholar
• Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. Br. Med. J. 310(6992), 1433–1438 (1995).
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int. Clin. Psychopharmacol. 9(Suppl. 4), 33–40 (1995).
   PubMed Web of Science ®Google Scholar
• Badamgarav E, Weingarten SR, Henning JM et al. Effectiveness of disease management programs in depression: a systematic review. Am. J. Psychiatry 160(12), 2080–2090 (2003).
   PubMed Web of Science ®Google Scholar
• Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane. Database. Syst. Rev. 2, CD000011 (2002).
   Google Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 23(8), 1296–1310 (2001).
   PubMed Web of Science ®Google Scholar
• Pampallona S, Bollini P, Tibaldi G et al. Patient adherence in the treatment of depression. Br. J. Psychiatry 180, 104–109 (2002).
   PubMed Web of Science ®Google Scholar
• Lin EH, Von KM, Ludman EJ et al. Enhancing adherence to prevent depression relapse in primary care. Gen. Hosp. Psychiatry 25(5), 303–310 (2003).
   PubMed Web of Science ®Google Scholar
• Vergouwen AC, Bakker A, Katon WJ et al. Improving adherence to antidepressants: a systematic review of interventions. J. Clin. Psychiatry 64(12), 1415–1420 (2003).
   Google Scholar
• Peveler R, George C, Kinmonth AL et al. Effect of antidepressant drug counseling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. Br. Med. J. 319(7210), 612–615 (1999).
   PubMed Web of Science ®Google Scholar
• Unutzer J, Rubenstein L, Katon WJ et al. Two-year effects of quality improvement programs on medication management for depression. Arch. Gen. Psychiatry 58(10), 935–942 (2001).
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Rush AJ, Crismon ML et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch. Gen. Psychiatry 61(7), 669–680 (2004).
   PubMed Web of Science ®Google Scholar
• Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA 289(23), 3145–3151 (2003).
   PubMed Web of Science ®Google Scholar
• Simon GE. Evidence review: efficacy and effectiveness of antidepressant treatment in primary care. Gen. Hosp. Psychiatry 24(4), 213–224 (2002).
   PubMed Web of Science ®Google Scholar
• Wells K, Sherbourne C, Schoenbaum M et al. Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial. Arch. Gen. Psychiatry 61(4), 378–386 (2004).
   PubMed Web of Science ®Google Scholar
• van Os TW, van den Brink RH, Tiemens BG et al. Are effects of depression management training for General Practitioners on patient outcomes mediated by improvements in the process of care? J. Affect. Disord. 80(2–3), 173–179 (2004).
   Google Scholar
• Oxman TE, Dietrich AJ, Schulberg HC. The depression care manager and mental health specialist as collaborators within primary care. Am. J. Geriatr. Psychiatry. 11(5), 507–516 (2003).
   PubMed Web of Science ®Google Scholar
• Dietrich AJ, Oxman TE, Williams JW Jr et al. Re-engineering systems for the treatment of depression in primary care: cluster randomised controlled trial. Br. Med. J. 329(7466), 602 (2004).
   PubMed Web of Science ®Google Scholar
• Hunkeler EM, Katon W, Tang L et al. Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. Br. Med. J. 332(7536), 259–263 (2006).
   PubMed Web of Science ®Google Scholar
• Von KM, Unutzer J, Katon W, Wells K. Improving care for depression in organized health care systems. J. Fam. Pract. 50(6), 530–531 (2001).
   Google Scholar
• Simon G. Collaborative care for depression. Br. Med. J. 332(7536), 249–250 (2006).
   PubMedGoogle Scholar
• Von KM, Goldberg D. Improving outcomes in depression. Br. Med. J. 323(7319), 948–949 (2001).
   Google Scholar
• Bridson J, Hammond C, Leach A, Chester MR. Making consent patient centred. Br. Med. J. 327(7424), 1159–1161 (2003).
   PubMedGoogle Scholar
• Lewis DK, Robinson J, Wilkinson E. Factors involved in deciding to start preventive treatment: qualitative study of clinicians’ and lay people’s attitudes. Br. Med. J. 327(7419), 841 (2003).
   PubMed Web of Science ®Google Scholar
• Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. Am. J. Psychiatry 159(8), 1354–1360 (2002).
   PubMed Web of Science ®Google Scholar
• Frank E, Kupfer DJ, Perel JM et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch. Gen. Psychiatry. 47(12), 1093–1099 (1990).
   PubMed Web of Science ®Google Scholar
• Reynolds CF, III, Frank E, Perel JM et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 281(1), 39–45 (1999).
   PubMed Web of Science ®Google Scholar
• Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch. Gen. Psychiatry 61(7), 714–719 (2004).
   PubMed Web of Science ®Google Scholar